CFM
MD icon

Catalyst Funds Management’s Pediatrix Medical MD Stock Holding History

Catalyst Funds Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600
Closed -$4.53K – 1484
2024
Q2 		$4.53K Buy
600
+400
+200% +$3.31K ﹤0.01% 1074
2024
Q1 		$2.01K Buy
+200
New +$1.86K ﹤0.01% 1053

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Catalyst Funds Management's MD Position: Q3 2024 in Review

Catalyst Funds Management sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 600 shares — an estimated $4.53K sold.

Catalyst Funds Management first reported a position in MD in Q1 2024 and held it in 2 quarters. The position peaked at $4.53K in Q2 2024. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

  • Catalyst Funds Management reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 600 Pediatrix Medical shares in Q3 2024, an estimated $4.53K.
  • Catalyst Funds Management first reported a position in Pediatrix Medical in Q1 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Pediatrix Medical position peaked at $4.53K in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Catalyst Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.